The global COPD therapeutics market garnered a market value of USD 12,144.1 million in 2023 and is expected to accumulate a market value of USD 20,035.5 million by 2033, registering a CAGR of 5.1% over the forecast period.
The growth of the COPD therapeutics market can be attributed to an increase in smoking and genetic disorders. The market for COPD therapeutics registered a CAGR of 4.8% during the historical period.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2022) | USD 11,668.2 million |
| Expected Market Value (2023) | USD 12,144.1 million |
| Anticipated Forecast Value (2033) | USD 20,035.5 million |
| Projected Growth Rate (2023 to 2033) | 5.1% CAGR |
Surgery is recommended in case of the extreme severity of COPD, including lung volume reduction surgery, lung transplant, and bullectomy, and the adoption of COPD therapeutics rises as COPD is one of the leading causes of death worldwide.
Triple therapy, LABA-ICS, LAMA-ICS, and other combination medications are examples of combination therapy. As using a bronchodilator and a corticosteroid separately is less effective, combination therapy is becoming more popular, positively impacting the market outlook.
Combination therapy is superior to monotherapy for treating the signs and symptoms of chronic obstructive pulmonary disease and enhancing the quality of life. Moreover, the COPD therapeutics market growth is anticipated to rise as a result of a rise in the number of patients who are successfully treated with combination therapy but did not improve after receiving bronchodilators or corticosteroids.
Lifestyle change is responsible for increasing the habits like smoking and increase in the number of genetic disorders, which in turn are responsible for raising the number of COPD patients and expanding the COPD therapeutics market size.
Other factors that can boost the revenue from the COPD therapeutics market are rising healthcare expenditures, leading to the adoption of COPD treatments in emerging economies. The demand for COPD therapeutics can also be owed to an increase in the level of awareness which has also led to the early diagnosis of COPD so that people can go for the treatment of the disease.
Additionally, it is projected that new product launches and advances in the global market for Chronic Obstructive Pulmonary therapeutics in respiratory illness therapy will aid in the industry's expansion. Betterment of the healthcare infrastructure in the Asia Pacific and the Middle East, and Africa is also responsible for the revenue growth of the COPD therapeutics market during the forecast period.
Factors that can limit the growth of the therapeutic enzymes over the forecast period include the fact that not all patients suffering from COPD are aware of the fact that they are suffering from the disease and therefore do not go for the treatment of the disease.
Also, sometimes people get to know about their disease when only medication and therapies, and surgery can’t cure the disease becomes mandatory. This factor can also lead to sluggish growth in the revenue from the COPD therapeutics market.
| Region | North America |
|---|---|
| Market Share % (2022) | 36.2% |
According to National Heart, Lung, and Blood Institute, more than 15 million people are affected by COPD. This has increased the dependency on COPD therapeutics to access early treatment for the same. In addition, the strong presence of key players in the region is accelerating the growth of the COPD therapeutics market.
Moreover, developing health infrastructure is fuelling the growth of the COPD therapeutics market. Thus, due to the aforementioned reasons, North America is expected to possess more than 36.2% market share for COPD therapeutics in 2023.
| Region | Europe |
|---|---|
| Market Share % (2022) | 29.8% |
According to Asthma Lung UK+, more than 1.3 million people suffer from COPD. This has led the country's government to design initiatives to create awareness regarding COPD. In addition, the increasing geriatric population in the country is contributing to the growth of the COPD market.
Furthermore, the growing inclination towards early treatment positively influences the market's growth. Thus, due to the reasons mentioned above, Europe is expected to hold a more than 29.8% COPD therapeutics market share in 2023.
Key start-up players in the COPD therapeutics market are Omnispirant, Atriva Therapeutics, Altavant Sciences, Exvastat, and ReAlta Life Sciences.
The COPD market is consolidated, with only a few significant firms present, and the primary strategies used by the top companies are product portfolio expansion and mergers and acquisitions.
One of the major recent developments in the COPD therapeutics market is when AstraZeneca’s Bevespi Aerospherehas received approval in China as a maintenance treatment to relieve symptoms in patients suffering from COPD.
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 12,144.1 million |
| Market Value in 2033 | USD 20,035.5 million |
| Growth Rate | CAGR of 5.1% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Component, End User, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East and Africa |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, Japan, South Korea, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | Pfizer Inc.; Adamis Laboratories Inc.; GlaxoSmithKline plc; AstraZeneca; Merk & Co; Novartis AG; Mylan N.V.; Teva Pharmaceutical Industries |
| Customization | Available Upon Request |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Component, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Component, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: Latin America Market Value (US$ Million) Forecast by Component, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 11: Western Europe Market Value (US$ Million) Forecast by Component, 2018 to 2033
Table 12: Western Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Eastern Europe Market Value (US$ Million) Forecast by Component, 2018 to 2033
Table 15: Eastern Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Component, 2018 to 2033
Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 20: East Asia Market Value (US$ Million) Forecast by Component, 2018 to 2033
Table 21: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Component, 2018 to 2033
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Component, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by End User, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Global Market Value (US$ Million) Analysis by Component, 2018 to 2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Component, 2023 to 2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033
Figure 10: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 13: Global Market Attractiveness by Component, 2023 to 2033
Figure 14: Global Market Attractiveness by End User, 2023 to 2033
Figure 15: Global Market Attractiveness by Region, 2023 to 2033
Figure 16: North America Market Value (US$ Million) by Component, 2023 to 2033
Figure 17: North America Market Value (US$ Million) by End User, 2023 to 2033
Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Component, 2018 to 2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Component, 2023 to 2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 28: North America Market Attractiveness by Component, 2023 to 2033
Figure 29: North America Market Attractiveness by End User, 2023 to 2033
Figure 30: North America Market Attractiveness by Country, 2023 to 2033
Figure 31: Latin America Market Value (US$ Million) by Component, 2023 to 2033
Figure 32: Latin America Market Value (US$ Million) by End User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Component, 2018 to 2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Component, 2023 to 2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 43: Latin America Market Attractiveness by Component, 2023 to 2033
Figure 44: Latin America Market Attractiveness by End User, 2023 to 2033
Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 46: Western Europe Market Value (US$ Million) by Component, 2023 to 2033
Figure 47: Western Europe Market Value (US$ Million) by End User, 2023 to 2033
Figure 48: Western Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 52: Western Europe Market Value (US$ Million) Analysis by Component, 2018 to 2033
Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Component, 2023 to 2033
Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033
Figure 55: Western Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 58: Western Europe Market Attractiveness by Component, 2023 to 2033
Figure 59: Western Europe Market Attractiveness by End User, 2023 to 2033
Figure 60: Western Europe Market Attractiveness by Country, 2023 to 2033
Figure 61: Eastern Europe Market Value (US$ Million) by Component, 2023 to 2033
Figure 62: Eastern Europe Market Value (US$ Million) by End User, 2023 to 2033
Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Component, 2018 to 2033
Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Component, 2023 to 2033
Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033
Figure 70: Eastern Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 73: Eastern Europe Market Attractiveness by Component, 2023 to 2033
Figure 74: Eastern Europe Market Attractiveness by End User, 2023 to 2033
Figure 75: Eastern Europe Market Attractiveness by Country, 2023 to 2033
Figure 76: South Asia and Pacific Market Value (US$ Million) by Component, 2023 to 2033
Figure 77: South Asia and Pacific Market Value (US$ Million) by End User, 2023 to 2033
Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Component, 2018 to 2033
Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Component, 2023 to 2033
Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033
Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 88: South Asia and Pacific Market Attractiveness by Component, 2023 to 2033
Figure 89: South Asia and Pacific Market Attractiveness by End User, 2023 to 2033
Figure 90: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033
Figure 91: East Asia Market Value (US$ Million) by Component, 2023 to 2033
Figure 92: East Asia Market Value (US$ Million) by End User, 2023 to 2033
Figure 93: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 97: East Asia Market Value (US$ Million) Analysis by Component, 2018 to 2033
Figure 98: East Asia Market Value Share (%) and BPS Analysis by Component, 2023 to 2033
Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033
Figure 100: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 101: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 102: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 103: East Asia Market Attractiveness by Component, 2023 to 2033
Figure 104: East Asia Market Attractiveness by End User, 2023 to 2033
Figure 105: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 106: Middle East and Africa Market Value (US$ Million) by Component, 2023 to 2033
Figure 107: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033
Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Component, 2018 to 2033
Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Component, 2023 to 2033
Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Component, 2023 to 2033
Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 118: Middle East and Africa Market Attractiveness by Component, 2023 to 2033
Figure 119: Middle East and Africa Market Attractiveness by End User, 2023 to 2033
Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
The market in 2023 is valued at USD 12,144.1 million.
The market rose at a 4.8% CAGR from 2018 to 2022.
The market will register a 5.1% CAGR until 2033.
By 2033, the market will reach USD 20,035.5 million.
Europe’s market share in 2022 was 29.8%.
Explore Similar Insights
COPD Therapeutics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
